Skip to main content
# Title Research Year
251 Serum levels of IL-12 and IL-23 in psoriatic patients with or without concomitant
hepatitis C: A comparative study
2016
252 Pharmacogenomics and chemical library screens reveal a novel
SCFSKP2 inhibitor that overcomes Bortezomib resistance in
multiple myeloma
2016
253 Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) as Non-Invasive Biomarkers of Remodelling in Asthma 2015
254 Vitamin D status and viral response to therapy in hepatitis C infected children 2015
255 Methylated gene p15 and APC gene As biomarkers in Detection of HCC Versus MRI Diffusion In Cirrhotic Patients
2015
256 SUBCLINICAL RENAL AFFECTION IN PATIENTS WITH Β-THALASSEMIA MAJOR: IN RELATION TO CHELATION THERAPY VERSUS BLOOD TRANSFUSION THERAPY. 2015
257 percutaneous collagen induction using dermaroller versus 80% trichloroacetic acid in the treatment of atrophic post acne scars: a comparative study. 2015
258 Human telomerase reverse transcriptase mRNA as a novel tumor marker for hepatocellular carcinoma 2015
259 Abstract A18: MicroRNA-29b replacement inhibits proteasomes and disrupts the aggresome-autophagy pathway to enhance the antimyeloma benefit of bortezomib. 2015
260 Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) as Non-Invasive Biomarkers of Remodelling in Asthma 2015